ET
NEO icon

Entropy Technologies’s NeoGenomics NEO Stock Holding History

Entropy Technologies’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,037
Closed -$271K – 1069
2025
Q4 		$271K Buy
23,037
+1,480
+7% +$16K 0.01% 731
2025
Q3 		$166K Buy
21,557
+5,167
+32% +$36.2K 0.01% 764
2025
Q2 		$120K Buy
+16,390
New +$132K 0.01% 739

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Entropy Technologies's NEO Position: Q1 2026 in Review

Entropy Technologies sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 23,037 shares — an estimated $271K sold.

Entropy Technologies first reported a position in NEO in Q2 2025 and held it in 3 quarters. The position peaked at $271K in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Entropy Technologies reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 23,037 NeoGenomics shares in Q1 2026, an estimated $271K.
  • Entropy Technologies first reported a position in NeoGenomics in Q2 2025 and held it in 3 quarters.
  • Entropy Technologies's NeoGenomics position peaked at $271K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.